The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and… Read More
A new biotech startup has hatched from the University of Washington’s Institute for Protein Design with $6 million in funding and a leadership team fresh from Neoleukin Therapeutics, another IPD… Read More
For 30 years, scientists have been trying to unleash the promise of Interleukin-2 (IL-2), a powerful protein that fights cancer but is highly toxic. Researchers at the University of Washington… Read More